JP2023076596A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023076596A5 JP2023076596A5 JP2023060823A JP2023060823A JP2023076596A5 JP 2023076596 A5 JP2023076596 A5 JP 2023076596A5 JP 2023060823 A JP2023060823 A JP 2023060823A JP 2023060823 A JP2023060823 A JP 2023060823A JP 2023076596 A5 JP2023076596 A5 JP 2023076596A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- amino acid
- acid sequence
- set forth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2024576 | 2019-12-24 | ||
| NL2024576 | 2019-12-24 | ||
| PCT/NL2020/050813 WO2021133167A1 (en) | 2019-12-24 | 2020-12-22 | Tgf-beta-rii binding proteins |
| JP2022539245A JP7633259B2 (ja) | 2019-12-24 | 2020-12-22 | ＴＧＦ－βＲＩＩ結合タンパク質 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539245A Division JP7633259B2 (ja) | 2019-12-24 | 2020-12-22 | ＴＧＦ－βＲＩＩ結合タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023076596A JP2023076596A (ja) | 2023-06-01 |
| JP2023076596A5 true JP2023076596A5 (https=) | 2023-08-22 |
Family
ID=69700252
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539245A Active JP7633259B2 (ja) | 2019-12-24 | 2020-12-22 | ＴＧＦ－βＲＩＩ結合タンパク質 |
| JP2023060823A Pending JP2023076596A (ja) | 2019-12-24 | 2023-04-04 | ＴＧＦ－βＲＩＩ結合タンパク質 |
| JP2025018365A Pending JP2025083342A (ja) | 2019-12-24 | 2025-02-06 | ＴＧＦ－βＲＩＩ結合タンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539245A Active JP7633259B2 (ja) | 2019-12-24 | 2020-12-22 | ＴＧＦ－βＲＩＩ結合タンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025018365A Pending JP2025083342A (ja) | 2019-12-24 | 2025-02-06 | ＴＧＦ－βＲＩＩ結合タンパク質 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12570747B2 (https=) |
| EP (2) | EP4269433A3 (https=) |
| JP (3) | JP7633259B2 (https=) |
| KR (2) | KR20230145542A (https=) |
| CN (3) | CN116199780A (https=) |
| AR (2) | AR120914A1 (https=) |
| AU (2) | AU2020412201B2 (https=) |
| BR (1) | BR112022012522A2 (https=) |
| IL (2) | IL294181A (https=) |
| MX (2) | MX2022007919A (https=) |
| PH (1) | PH12022551527A1 (https=) |
| TW (2) | TW202417513A (https=) |
| WO (1) | WO2021133167A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116199780A (zh) * | 2019-12-24 | 2023-06-02 | 美勒斯公司 | TGF-β-RII结合蛋白质 |
| CA3231649A1 (en) * | 2021-11-19 | 2023-05-25 | Cecilia Anna Wilhelmina Geuijen | Multispecific binding moieties comprising pd-1 and tgf-brii binding domains |
| CN121736114A (zh) | 2022-12-20 | 2026-03-27 | 美勒斯公司 | FAP结合域以及结合FAP和TGF-βRII的双特异性结合部分 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001206899A (ja) * | 1999-11-18 | 2001-07-31 | Japan Tobacco Inc | ＴＧＦ−βＩＩ型受容体に対するヒトモノクローナル抗体及びその医薬用途 |
| NZ537277A (en) | 2002-07-18 | 2008-04-30 | Crucell Holland Bv | Recombinant production of mixtures of antibodies |
| PL3456190T3 (pl) | 2008-06-27 | 2022-06-06 | Merus N.V. | Wytwarzające przeciwciała transgeniczne zwierzę z gatunku myszy |
| JO3096B1 (ar) | 2008-11-07 | 2017-03-15 | Imclone Llc | الأجسام المضادة لمستقبل ii مضاد tgfb |
| JP6062375B2 (ja) * | 2011-01-06 | 2017-01-18 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | Ｔｇｆ−ベータ受容体ｉｉに結合するリガンド |
| EP3470431A1 (en) | 2012-09-27 | 2019-04-17 | Merus N.V. | Bispecific igg antibodies as t cell engagers |
| JP2018527903A (ja) * | 2015-07-22 | 2018-09-27 | スカラー ロック インコーポレイテッドＳｃｈｏｌａｒ Ｒｏｃｋ，Ｉｎｃ． | Ｇｄｆ１１結合タンパク質およびその使用 |
| TW201825519A (zh) | 2016-10-18 | 2018-07-16 | 美商美國禮來大藥廠 | TGFβ受體II抗體 |
| MX2020010267A (es) | 2018-03-30 | 2020-11-06 | Merus Nv | Anticuerpo multivalente. |
| CN116199780A (zh) * | 2019-12-24 | 2023-06-02 | 美勒斯公司 | TGF-β-RII结合蛋白质 |
-
2020
- 2020-12-22 CN CN202211726462.2A patent/CN116199780A/zh active Pending
- 2020-12-22 EP EP23189839.6A patent/EP4269433A3/en active Pending
- 2020-12-22 IL IL294181A patent/IL294181A/en unknown
- 2020-12-22 JP JP2022539245A patent/JP7633259B2/ja active Active
- 2020-12-22 US US17/757,953 patent/US12570747B2/en active Active
- 2020-12-22 WO PCT/NL2020/050813 patent/WO2021133167A1/en not_active Ceased
- 2020-12-22 AU AU2020412201A patent/AU2020412201B2/en active Active
- 2020-12-22 MX MX2022007919A patent/MX2022007919A/es unknown
- 2020-12-22 PH PH1/2022/551527A patent/PH12022551527A1/en unknown
- 2020-12-22 EP EP20829233.4A patent/EP4081306A1/en active Pending
- 2020-12-22 CN CN202080094188.4A patent/CN115038497A/zh active Pending
- 2020-12-22 BR BR112022012522A patent/BR112022012522A2/pt unknown
- 2020-12-22 CN CN202211726434.0A patent/CN116375869A/zh active Pending
- 2020-12-22 KR KR1020237034290A patent/KR20230145542A/ko active Pending
- 2020-12-22 KR KR1020227023748A patent/KR20220117267A/ko active Pending
- 2020-12-23 TW TW112150430A patent/TW202417513A/zh unknown
- 2020-12-23 AR ARP200103661A patent/AR120914A1/es unknown
- 2020-12-23 TW TW109145819A patent/TW202128747A/zh unknown
-
2022
- 2022-06-23 MX MX2024002182A patent/MX2024002182A/es unknown
-
2023
- 2023-02-13 AU AU2023200779A patent/AU2023200779B2/en active Active
- 2023-04-04 JP JP2023060823A patent/JP2023076596A/ja active Pending
- 2023-07-09 IL IL304317A patent/IL304317A/en unknown
- 2023-11-07 AR ARP230102989A patent/AR130991A2/es unknown
-
2025
- 2025-02-06 JP JP2025018365A patent/JP2025083342A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11578131B2 (en) | Polynucleotides encoding death domain-containing receptor-5 (DR5) binding molecules | |
| JP2023076596A5 (https=) | ||
| JP6697064B2 (ja) | ｐＨ範囲で結合性が異なる薬物動態改善のための抗ＴＦＰＩ抗体変異体 | |
| JP2020501531A5 (https=) | ||
| CA2942546C (en) | Antibody-fynomer conjugates | |
| EP3105246B1 (en) | Targeted tgf beta inhibition | |
| ME02371B (me) | Sastojci i postupci za dijagnstikovanje i tretman raka | |
| JP2020513809A5 (https=) | ||
| JP2019532619A5 (https=) | ||
| RU2013125459A (ru) | АНТИТЕЛА ПРОТИВ БЕЛКА РЕЦЕПТОРА c-Met | |
| AU2019224136A1 (en) | Use of a multimeric anti-DR5 binding molecule in combination with a chemotherapeutic agent for treating cancer | |
| JP2018503365A5 (https=) | ||
| JPWO2021139777A5 (https=) | ||
| CN110945027A (zh) | GARP-TGF-β抗体 | |
| CA3173919A1 (en) | Use of a multimeric anti-dr5 binding molecule in combination with a cancer therapy for treating cancer | |
| IL268000B2 (en) | Cancer treatment with semphorin-4d antibody in combination with an epigenetic modulator factor | |
| CN114269782A (zh) | 抗tigit抗体及其应用 | |
| WO2020200256A1 (zh) | 一种融合蛋白及其用途 | |
| TW201825515A (zh) | Ｍｅｔ抗體以及其免疫結合物及用途 | |
| TW202124432A (zh) | 使用pd-1軸抑制劑及抗骨膜蛋白抗體治療癌症之方法 | |
| CN116724057A (zh) | 蛋白酶可切割的重组双特异性抗体和组合物及其用途 | |
| CN112996540B (zh) | 一种c-Met ADC在制备治疗c-Met激酶抑制剂耐药的疾病的药物中的用途 | |
| JP2021531263A (ja) | 抗ヒトｐｄ−ｌ１抗体とその使用 | |
| JPWO2021190622A5 (https=) | ||
| JPWO2021133167A5 (https=) |